FdaApplication
ANDA 214955
Identifiers
- fda_app_no: ANDA214955
Properties
| Property | Value |
|---|---|
| applicant_name | NE RX PHARMA LLC |
| application_type | ANDA |
| approval_date | 2022-08-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BUTALBITAL AND ACETAMINOPHEN | ACETAMINOPHEN; BUTALBITAL | 300MG;50MG | TABLET;ORAL |
1 product